23 February 2017 - - US-based medical device maker Electromed, Inc. (NYSE MKT: ELMD) has entered into an agreement with US-based medical device maker Monaghan Medical Corp. to distribute and sell the Aerobika Oscillating Positive Expiratory Pressure Device in the United States homecare market, the company said.

Electromed will begin sales of the Aerobika OPEP device in targeted geographies in the third quarter of its fiscal 2017, with planned expansion prior to the end of the fiscal year.

The Aerobika OPEP device is a drug-free, easy to use, hand-held device with a proprietary pressure-oscillation dynamic that provides intermittent resistance and creates positive pressure and oscillations simultaneously.

The Aerobika OPEP device opens weak or collapsed airways to mobilize and assist mucociliary clearance to the upper airways where it can be coughed out.

According to Electromed, clinical evidence demonstrates that using the Aerobika OPEP device improves the ability to bring up mucus, decreases cough frequency and breathlessness, and increases exercise tolerance resulting in a better quality of life.

Electromed said it plans to distribute the Aerobika OPEP device directly to patients, upon receipt of physician prescriptions. Electromed currently anticipates minimal impact to fiscal 2017 revenues and expenses resulting from the new agreement.

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function.

It is headquartered in New Prague, Minnesota and founded in 1992.

Monaghan Medical offers aerosol drug delivery devices and respiratory management products, including the AeroEclipse II Breath-Actuated Nebulizer, AeroChamber brand of Valved Holding Chambers and the Aerobika OPEP device.